Back
Guidewire Software Vs. Viking Therapeutics Industry Stock Comparison
Buy
67
GWRE
Guidewire Software
Last Price:
186.87
Seasonality Move:
3.91%
Sell
45
VKTX
Viking Therapeutics
Last Price:
64.72
Seasonality Move:
38.04%
Buy
67
Guidewire Software (GWRE)
is a Buy
Is Guidewire Software a Buy, Sell or Hold?
- The current Guidewire Software [GWRE] share price is $185.52. The Score for GWRE is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- GWRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GWRE Stock Price Chart
What is Guidewire Software's stock price today?
-
The Guidewire Software share price today is $185.52
The current trend is moderately bullish and GWRE is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $63.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
GWRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.19 | Buy |
Relative Strength Index (14 RSI): | 55.82 | Buy |
Chaikin Money Flow: | -87391 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (183.1 - 188.66) | Sell |
Bollinger Bands (100): | (138.46 - 177.78) | Buy |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.92 | Buy |
Relative Strength Index (14 RSI): | 44.37 | Sell |
Chaikin Money Flow: | -27799915 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (62.04 - 71.46) | Sell |
Bollinger Bands (100): | (52.9 - 66.58) | Buy |
GWRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 187.34 | Sell |
20-day SMA: | 186.81 | Sell |
50-day SMA: | 174.49 | Buy |
200-day SMA: | 137.17 | Buy |
8-day EMA: | 186.91 | Sell |
20-day EMA: | 185.32 | Buy |
50-day EMA: | 175.52 | Buy |
200-day EMA: | 142.64 | Buy |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.43 | Sell |
20-day SMA: | 67.48 | Sell |
50-day SMA: | 64.43 | Sell |
200-day SMA: | 59.82 | Buy |
8-day EMA: | 69.69 | Sell |
20-day EMA: | 68.14 | Sell |
50-day EMA: | 65.07 | Sell |
200-day EMA: | 55.33 | Buy |
Guidewire Software Earnings Growth & GWRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.29 per share, and an increase next year of $0.67 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Guidewire Software Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |